Brown Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67M Sell
693,149
-219,613
-24% -$22.5M 0.11% 140
2025
Q4
$96.9M Sell
912,762
-100,033
-10% -$11.6M 0.14% 120
2025
Q3
$129M Sell
1,012,795
-55,696
-5% -$6.63M 0.17% 106
2025
Q2
$131M Sell
1,068,491
-272,229
-20% -$31.1M 0.17% 97
2025
Q1
$136M Sell
1,340,720
-78,909
-6% -$7.7M 0.19% 97
2024
Q4
$131M Sell
1,419,629
-72,213
-5% -$7.09M 0.17% 108
2024
Q3
$144M Sell
1,491,842
-70,372
-5% -$6.32M 0.18% 99
2024
Q2
$134M Sell
1,562,214
-178,366
-10% -$15M 0.18% 100
2024
Q1
$144M Sell
1,740,580
-50,937
-3% -$3.73M 0.19% 99
2023
Q4
$120M Buy
1,791,517
+104,847
+6% +$6.79M 0.17% 104
2023
Q3
$113M Sell
1,686,670
-13,798
-0.8% -$949K 0.19% 106
2023
Q2
$115M Buy
1,700,468
+30,347
+2% +$1.9M 0.18% 106
2023
Q1
$90.4M Buy
1,670,121
+97,698
+6% +$5.69M 0.15% 126
2022
Q4
$94M Buy
1,572,423
+25,336
+2% +$1.38M 0.17% 118
2022
Q3
$70M Sell
1,547,087
-4,471
-0.3% -$224K 0.14% 138
2022
Q2
$69.2M Buy
1,551,558
+6,016
+0.4% +$309K 0.13% 144
2022
Q1
$87.4M Buy
1,545,542
+96,114
+7% +$5.02M 0.13% 131
2021
Q4
$75.3M Buy
1,449,428
+70,513
+5% +$3.64M 0.09% 154
2021
Q3
$82.3M Buy
1,378,915
+116,441
+9% +$7.33M 0.12% 140
2021
Q2
$78.4M Buy
1,262,474
+64,270
+5% +$4.28M 0.12% 149
2021
Q1
$78.1M Buy
1,198,204
+49,433
+4% +$3.22M 0.13% 133
2020
Q4
$75.6M Buy
1,148,771
+32,462
+3% +$1.91M 0.13% 127
2020
Q3
$57.7M Buy
1,116,309
+132,441
+13% +$6.8M 0.12% 127
2020
Q2
$48.5M Buy
983,868
+558,291
+131% +$30.1M 0.11% 137
2020
Q1
$21.7M Buy
+425,577
New +$24.5M 0.07% 197
2017
Q4
Sell
-14,774
Closed -$545K 1237
2017
Q3
$545K Buy
14,774
+1,789
+14% +$63.7K ﹤0.01% 823
2017
Q2
$500K Buy
12,985
+2,924
+29% +$107K ﹤0.01% 856
2017
Q1
$344K Buy
+10,061
New +$330K ﹤0.01% 923

Other funds holding EHC

Brown Advisory's EHC Position: Q1 2026 in Review

Brown Advisory reduced its Encompass Health (EHC) stake by 24% in Q1 2026, selling an estimated $22.5M and leaving 693,149 shares worth $67M. The position accounts for 0.11% of the portfolio, ranked #140.

Brown Advisory first reported a position in EHC in Q1 2017 and has held it in 28 quarters since. The position peaked at $144M in Q3 2024. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Brown Advisory held 693,149 shares of Encompass Health worth $67M as of Q1 2026.
  • Brown Advisory sold 219,613 Encompass Health shares in Q1 2026, an estimated $22.5M.
  • Encompass Health made up 0.11% of Brown Advisory's portfolio in Q1 2026, its #140 holding.
  • Brown Advisory first reported a position in Encompass Health in Q1 2017 and has held it in 28 quarters since.
  • Brown Advisory's Encompass Health position peaked at $144M in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.